ACE2 and susceptibility to pneumonia measurement: It is intriguing to suggest that perhaps this small population of ACE2-expressing cells may underlie the pathogenesis of severe ARDS, pneumonia, and respiratory failure in COVID-19 patients and, perhaps, particularly in those with LUAD.